[1]
|
Cotter, T.G. and Rinella, M. (2020) Nonalcoholic Fatty Liver Disease 2020: The State of the Disease. Gastroenterology, 158, 1851-1864. https://doi.org/10.1053/j.gastro.2020.01.052
|
[2]
|
Zhou, J., Zhou, F., Wang, W., et al. (2020) Ep-idemiological Features of NAFLD from 1999 to 2018 in China. Hepatology, 71, 1851-1864. https://doi.org/10.1002/hep.31150
|
[3]
|
(2018) Global Prevalence, Treatment, and Prevention of Hepatitis B Virus Infection in 2016: A Modelling Study. The Lancet Gastroenterology and Hepatology, 3, 383-403. https://doi.org/10.1016/S2468-1253(18)30056-6
|
[4]
|
Jelenik, T., Kaul, K., Séquaris, G., et al. (2017) Mechanisms of Insulin Resistance in Primary and Secondary Nonalcoholic Fatty Liver. Diabetes, 66, 2241-2253. https://doi.org/10.2337/db16-1147
|
[5]
|
Tilg, H. and Moschen, A.R. (2010) Evolution of Inflammation in Nonal-coholic Fatty Liver Disease: The Multiple Parallel Hits Hypothesis. Hepatology, 52, 1836-1846. https://doi.org/10.1002/hep.24001
|
[6]
|
Powell, E.E., Wong, V.W. and Rinella, M. (2021) Non-Alcoholic Fatty Liver Disease. The Lancet, 397, 2212-2224.
https://doi.org/10.1016/S0140-6736(20)32511-3
|
[7]
|
Nassal, M. (2015) HBV cccDNA: Viral Persistence Reser-voir and Key Obstacle for a Cure of Chronic Hepatitis B. Gut, 64, 1972-1984. https://doi.org/10.1136/gutjnl-2015-309809
|
[8]
|
Zhang, Z., Pan, Q., Duan, X.Y., et al. (2012) Fatty Liver Reduces Hepatitis B Virus Replication in a Genotype B Hepatitis B Virus Transgenic Mice Model. Journal of Gastroenterology and Hepatology, 27, 1858-1864.
https://doi.org/10.1111/j.1440-1746.2012.07268.x
|
[9]
|
Hu, D., Wang, H., Wang, H., et al. (2018) Non-Alcoholic Hepatic Steatosis Attenuates Hepatitis B Virus Replication in an HBV-Immunocompetent Mouse Model. Hepatology In-ternational, 12, 438-446.
https://doi.org/10.1007/s12072-018-9877-7
|
[10]
|
Wang, M.M., Wang, G.S., Shen, F., et al. (2014) Hepatic Steato-sis is Highly Prevalent in Hepatitis B Patients and Negatively Associated with Virological Factors. Digestive Diseases and Sciences, 59, 2571-2579.
https://doi.org/10.1007/s10620-014-3180-9
|
[11]
|
Chu, C.M., Lin, D.Y. and Liaw, Y.F. (2013) Clinical and Viro-logical Characteristics Post HBsAg Seroclearance in Hepatitis B Virus Carriers with Hepatic Steatosisversus Those without. Digestive Diseases and Sciences, 58, 275-281.
https://doi.org/10.1007/s10620-012-2343-9
|
[12]
|
Mak, L.Y., Hui, R.W., Fung, J., et al. (2020) Diverse Effects of Hepatic Steatosis on Fibrosis Progression and Functional Cure in Virologically Quiescent Chronic Hepatitis B. Journal of Hepatology, 73, 800-806.
https://doi.org/10.1016/j.jhep.2020.05.040
|
[13]
|
Kim, G.A., Lim, Y.S., Han, S., et al. (2018) High Risk of Hepato-cellular Carcinoma and Death in Patients with Immune-Tolerant-Phase Chronic Hepatitis B. Gut, 67, 945-952. https://doi.org/10.1136/gutjnl-2017-314904
|
[14]
|
Sinn, D.H., Kim, S.E., Kim, B.K., et al. (2019) The Risk of Hepatocellular Carcinoma among Chronic Hepatitis B Virus-Infected Patients outside Current Treatment Criteria. Journal of Viral Hepatitis, 26, 1465-1472.
https://doi.org/10.1111/jvh.13185
|
[15]
|
Chen, Y.C., Jeng, W.J., Hsu, C.W., et al. (2020) Impact of Hepatic Steato-sis on Treatment Response in Nuclesos(t)ide Analogue-Treated HBeAg-Positive Chronic Hepatitis B: A Retrospective Study. BMC Gastroenterology, 20, Article No. 146. https://doi.org/10.1186/s12876-020-01289-w
|
[16]
|
Ate, F., Yaln, Z.M. and Alan, S. (2011) Impact of Liver Steatosis on Response to Pegylated Interferon Therapy in Patients with Chronic Hepatitis B. World Journal of Gastroenterology, 17, 4517-4522.
https://doi.org/10.3748/wjg.v17.i40.4517
|
[17]
|
Charatcharoenwitthaya, P., Pongpaibul, A., Kaosombatwattana, U., et al. (2017) The Prevalence of Steatohepatitis in Chronic Hepatitis B Patients and Its Impact on Disease Severity and Treatment Response. Liver International, 37, 542-551. https://doi.org/10.1111/liv.13271
|
[18]
|
Chang, X.J., Shi, Y.W., Wang, J., et al. (2021) Influence of Weight Management on the Prognosis of Steatohepatitis in Chronic Hepatitis B Patients during Antiviral Treatment. Hepatobiliary & Pancreatic Diseases International, 20, 416-425.
https://doi.org/10.1016/j.hbpd.2021.06.009
|
[19]
|
Kim, D.S., Jeon, M.Y., Lee, H.W., et al. (2019) Influence of He-patic Steatosis on the Outcomes of Patients with Chronic Hepatitis B Treated with Entecavir and Tenofovir. Clinical and Molecular Hepatology, 25, 283-293.
https://doi.org/10.3350/cmh.2018.0054
|
[20]
|
Kim, K.H., Shin, H.J., Kim, K., et al. (2007) Hepatitis B Virus X Pro-tein Induces Hepatic Steatosis via Transcriptional Activation of SREBP1 and PPARgamma. Gastroenterology, 132, 1955-1967.
https://doi.org/10.1053/j.gastro.2007.03.039
|
[21]
|
Kim, J.Y., Song, E.H., Lee, H.J., et al. (2010) HBx-Induced He-patic Steatosis and Apoptosis Are Regulated by TNFR1- and NF-kappaB-Dependent Pathways. Journal of Molecular Biology, 397, 917-931.
https://doi.org/10.1016/j.jmb.2010.02.016
|
[22]
|
Oehler, N., Volz, T., Bhadra, O.D., et al. (2014) Binding of Hepati-tis B Virus to Its Cellular Receptor Alters the Expression Profile of Genes of Bile Acid Metabolism. Hepatology, 60, 1483-1493. https://doi.org/10.1002/hep.27159
|
[23]
|
Lin, Y.L., Shiao, M.S., Mettling, C., et al. (2003) Cholesterol Requirement of Hepatitis B Surface Antigen (HBsAg) Secretion. Virology, 314, 253-260. https://doi.org/10.1016/S0042-6822(03)00403-3
|
[24]
|
Okamura, H., Nio, Y., Akahori, Y., et al. (2016) Fatty Acid Biosynthesis Is Involved in the Production of Hepatitis B Virus Particles. Biochemical and Biophysical Research Com-munications, 475, 87-92.
https://doi.org/10.1016/j.bbrc.2016.05.043
|
[25]
|
Joo, E.J., Chang, Y., Yeom, J.S. and Ryu, S. (2017) Hepatitis B Virus Infection and Decreased Risk of Nonalcoholic Fatty Liver Disease: A Cohort Study. Hepatology, 65, 828-835. https://doi.org/10.1002/hep.28917
|
[26]
|
Zhong, G.C., Wu, Y.L., Hao, F.B., et al. (2018) Current but Not Past Hep-atitis B Virus Infection Is Associated with a Decreased Risk of Nonalcoholic Fatty Liver Disease in the Chinese Popula-tion: A Case-Control Study with Propensity Score Analysis. Journal of Viral Hepatitis, 25, 842-852. https://doi.org/10.1111/jvh.12878
|
[27]
|
Razi, B., Alizadeh, S., Omidkhoda, A., et al. (2017) Association of Chronic Hepatitis B Infection with Metabolic Syndrome and Its Components: Meta-Analysis of Observational Studies. Diabetol-ogy & Metabolic Syndrome, 11, S939-S947.
https://doi.org/10.1016/j.dsx.2017.07.020
|
[28]
|
Tseng, C.H., Muo, C.H., Hsu, C., et al. (2016) Association of Hep-atitis B Virus Infection with Decreased Ischemic Stroke. Acta Neurologica Scandinavica, 134, 339-345. https://doi.org/10.1111/ane.12548
|
[29]
|
Sung, J., Song, Y.M., Choi, Y.H., et al. (2007) Hepatitis B Virus Seroposi-tivity and the Risk of Stroke and Myocardial Infarction. Stroke, 38, 1436-1441. https://doi.org/10.1161/STROKEAHA.106.466268
|
[30]
|
Liu, P.T., Hwang, A.C. and Chen, J.D. (2013) Combined Effects of Hepatitis B Virus Infection and Elevated Alanine Aminotransferase Levels on Dyslipidemia. Metabolism, 62, 220-225. https://doi.org/10.1016/j.metabol.2012.07.022
|
[31]
|
Wong, V.W., Wong, G.L., Chu, W.C., et al. (2012) Hepatitis B Virus Infection and Fatty Liver in the General Population. Journal of Hepatology, 56, 533-540. https://doi.org/10.1016/j.jhep.2011.09.013
|
[32]
|
Peleg, N., Issachar, A., Sneh Arbib, O., et al. (2019) Liver Steato-sis Is a Strong Predictor of Mortality and Cancer in Chronic Hepatitis B Regardless of Viral Load. JHEP Reports, 1, 9-16. https://doi.org/10.1016/j.jhepr.2019.02.002
|
[33]
|
Chan, A.W., Wong, G.L., Chan, H.Y., et al. (2017) Concurrent Fatty Liver Increases Risk of Hepatocellular Carcinoma among Patients with Chronic Hepatitis B. Journal of Gastroen-terology and Hepatology, 32, 667-676.
https://doi.org/10.1111/jgh.13536
|
[34]
|
Lee, Y.B., Ha, Y., Chon, Y.E., et al. (2019) Association between Hepatic Steatosis and the Development of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B. Clinical and Molecular Hepatology, 25, 52-64.
https://doi.org/10.3350/cmh.2018.0040
|
[35]
|
van Kleef, L.A., Choi, H., Brouwer, W.P., et al. (2021) Metabolic Dysfunction-Associated Fatty Liver Disease Increases Risk of Adverse Outcomes in Patients with Chronic Hepatitis B. JHEP Reports, 3, Article ID: 100350.
https://doi.org/10.1016/j.jhepr.2021.100350
|
[36]
|
Vilar-Gomez, E., Martinez-Perez, Y., Calzadilla-Bertot, L., et al. (2015) Weight Loss through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis. Gas-troenterology, 149, 367-378.e5.
https://doi.org/10.1053/j.gastro.2015.04.005
|